Services on Demand
Journal
Article
Indicators
-
Cited by SciELO
-
Access statistics
Related links
Cited by Google
-
Similars in SciELO
Similars in Google
Share
Arquivos de Neuro-Psiquiatria
Print version ISSN 0004-282X
Arq. Neuro-Psiquiatr. vol.71 no.2 São Paulo Feb. 2013
http://dx.doi.org/10.1590/S0004-282X2013000200018
IMAGES IN NEUROLOGY
Darkening of white hair in Parkinson's disease during use of levodopa rich Mucuna pruriens extract powder
Escurecimento do cabelo branco na doença de Parkinson durante tratamento com extrato em pó de Mucuna pruriens rico em levodopa
Renato P MunhozI; Hélio A G TeiveII
IMD MSc at State of Paraná Parkinson Association, Curitiba PR, Brazil
IIMD PhD at Movement Disorders Unit, Neurology Service, Universidade Federal do Paraná (UFPR), Curitiba PR, Brazil
An 85-year-old patient with stable Parkinson's disease (PD), treated with levodopa/carbidopa 250/25 mg tid. During a follow-up visit, it was noticed that her temporal white hair was getting progressively darker (Figure), starting after introduction of Mucuna pruriens extract (MPE) at a dose equivalent to 1000 mg of levodopa/day. Hair and beard darkening was recognized as a complication of treatment with levodopa in PD since its earliest introduction.1 DOPA/dopamine are intermediate metabolites in the production of melanin, therefore, this association is not surprising. After the addition of decarboxylase inhibitors, this phenomenon, probably related to peripheral effects of levodopa, became strikingly rare.
References
1. Reynolds NJ, Crossley J, Ferguson I, Peachey RD. Darkening of white hair in Parkinson's disease. Clin Exp Dermatol 1989;14:317-318. [ Links ]
Correspondence:
Renato Puppi Munhoz
Travessa Lange 225
80240-170 Curitiba PR - Brazil
E-mail: renatopuppi@yahoo.com
Received: 12 September 2012
Received in final form: 20 September 2012
Accepted: 27 September 2012
Conflict of interest: There is no conflict of interest to declare.